Mdr-Tb Module 3: Extended Regimen

MDR-TB Module 3: Extended Regimen

Johns Hopkins University School of Nursing

Treatment of MDR/XDR-TB: Patient selection and regimen design

DR-TB Training Network

MDR-TB Module 1: Standard Short Course Regimen

Johns Hopkins University School of Nursing

Multidrug-Resistant Tuberculosis (MDR-TB): Mycobacterium tuberculosis

Professor Dave Explains

New TB Treatment Regimens

Treatment of MDR TB (Multi-drug resistant tuberculosis)

LEARNING MEDICAL EDUCATION (LME)

MDR-TB Module 7: Putting It All Together Case Study

Johns Hopkins University School of Nursing

MDR-TB Module 4: Basics of MDR TB Pharmacology

Johns Hopkins University School of Nursing

MDR-TB Module 6: Baseline Evaluation and Ongoing Management

Johns Hopkins University School of Nursing

Short regimen is noninferior to long regimen for Rifampin-Resistant Tuberculosis

infocusrx today

Q&A - Session 3 - Access to Medicines and TB

Academic Medical Education

Management of MDR-TB: novel treatments and their expansion to low-resource settings

#EndTB Webinar: Rolling out new WHO guidelines on rapid diagnostics and drug-resistant TB treatment

GlobalTBProgramme

Quick Revision of Multidrug Resistant TB Regimens under National TB elimination Program

Pulmonology Read Aloud

9-month, MDR-TB treatment in HIV & non-HIV co-infected patients in Swaziland & Uzbekistan

Safety of new MDR TB drugs: results from the endTB observational study - Hewison C (EN)

Epicentre - MSF

Second line medications for MDR-TB treatment; new drugs in the pipeline

DR-TB Training Network

Launch of new, shorter treatment regimen for drug-resistant TB: Prof Norbert Ndjeka